Preparation of platelet-rich plasma as a tissue adhesive for experimental transplantation in rabbits

1477-9560-4-18 1477-9560 Original basic research Preparation of platelet-rich plasma as a tissue adhesive for experimental transplantation in rabbits Luengo Gimeno Federico fluengogimeno@fibertel.com.ar Gatto Silvia sgatto@cas.austral.edu.ar Ferro José jferro@cas.austral.edu.ar Croxatto Oscar Juan juan.croxatto@gmail.com Gallo Eduardo Juan jgallo@cas.austral.edu.ar

Department of Ophthalmology, Facultad de Ciencias Biomédicas, Universidad Austral, Av. Perón 1500, Pilar, B1629AHJ, Argentina

Transfusional Service, Hospital Universitario Austral, Universidad Austral, Av. Perón 1500, Pilar, B1629AHJ, Argentina

Department of Ophthalmic Pathology, Fundación Oftalmológica Argentina "Jorge Malbran", Azcuénaga 1077, Pb B, Buenos Aires, 1115 (falta el numero entero), Argentina

Thrombosis Journal 1477-9560 2006 4 1 18 http://www.thrombosisjournal.com/content/4/1/18 17005053 10.1186/1477-9560-4-18 03 8 2006 28 9 2006 28 9 2006 2006 Luengo Gimeno et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Purpose

Platelet-rich plasma (PRP) is an autologous substance with adhesive properties. We aimed at developing and testing the efficacy of a method for PRP preparation in rabbits.

Materials and methods

An in vitro study was carried out to obtain PRP from forty rabbits and to analyze the number of platelets and type of substance needed to trigger platelet activation. To induce platelet activation, 5%, 10%, 25% and 50% CaCl solutions were used. Then, an in vivo study was performed in twelve rabbits to test PRP adhesiveness in lamellar corneal graft. A control group made up of six rabbits underwent corneal transplantation without using PRP.

Results

5% CaCl was the most effective concentration in activating PRP, with a mean time of 19 minutes. An attached corneal flap was seen 3 months after surgery. A detached corneal button was seen in all controls.

Conclusion

Our method was able to produce rabbit-derived PRP with suitable properties for soft tissue adhesion. These results could be useful for researchers of the growing fields of tissue repair and experimental transplantation.

Background

The platelet-rich plasma (PRP) is an autologous product that concentrates a high number of platelets in a small volume of plasma 1. This product mimics the last step of the coagulation cascade, leading to the formation of a fibrin clot, which consolidates and adheres to the application site in a short period of time. Evidencing hemostatic and healing properties, PRP is able to hold tissues or materials in a required configuration 2. Its biocompatible and biodegradable properties prevent the PRP from inducing foreign body reactions, tissue necrosis, or extensive fibrosis 3. Absorption of the fibrin clot is achieved during wound healing within weeks following application 456. PRP has been used in humans in different kinds of transplant procedures such as dentistry 789, orthopedics 10, maxillofacial surgery 11, plastic surgery 1213 and ophthalmology 14. In addition, PRP may be considered a carrier for biological active agents 1516 and a healing substance causing less post-surgical pain 1718.

Although the preparation of PRP in humans is well known 19, its preparation in rabbits is more difficult due to the reduced volume of blood and the smaller size of this animal. A blood sample, large enough to prepare PRP but without being lethal to the animal, should be collected. Reports in the literature differ about the intensity and duration of blood centrifugation, the number of platelets present in the PRP, and the use of thrombin or other factors to activate PRP 1320. Investigations also disagree on the puncture site and the quantity of blood that should be drawn from rabbits 202122. Furthermore, published studies lack an in vivo test of PRP adhesiveness in rabbits, animal frequently used in experimental transplantation.

The aim of our study was to obtain an ideal PRP solution for tissue adhesiveness and to test the effectiveness of the compound on lamellar corneal grafts using an in-vivo rabbit eye model.

Materials and methods

The investigation was conducted in two steps. First, an in vitro study was performed to determine the best method for obtaining PRP from rabbits. An in vivo study was carried out then to evaluate the adhesiveness of the obtained PRP to soft tissue.

Forty adult New Zealand white rabbits weighing 3,000 grams each were used. Eighteen were female and twenty-two were male. The rabbits were treated in accordance with the guidelines of the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research 23.

In vitro study

Seventy-three blood samples from twenty-eight rabbits were collected. An 8.7 ml intracardiac blood sample was drawn under strict aseptic conditions. All animals received general anesthesia using a combination of midazolam 1 mg/kg intramuscular (Roche, Basel, Switzerland) and ketamine 70 mg/kg intramuscular (Fada, Buenos Aires, Argentina). The blood was aspirated with a 21 G needle. A 10 ml syringe preloaded with 1.3 ml of Anticoagulant Citrate Dextrose (ACD) solution was used to avoid coagulation. One millimeter was set apart for cell counting. The procedure was performed by two investigators (JF and SG).

Each blood sample was centrifuged for 15 minutes at 72 g at 4°C resulting in the three following layers: the inferior layer composed of red cells, the intermediate layer composed of white cells and the superior layer made up of plasma. The 6 ml plasma layer was centrifuged for another 5 minutes at 1006 g in order to obtain a two-part plasma: the upper part consisting of 5.5 ml of poor-platelet plasma (PPP) and the lower part consisting of 0.5 ml of platelet-rich plasma (PRP). The PPP was first aspirated to avoid its mixing up with the PRP. The PRP was then gently aspirated with another pipette and placed in a sterile tube. The PRP was thus prepared for activation by calcium chloride (CaCl), which inhibits the blood-thinning effect of ACD. After activation, PRP turned into a gel-like solution with adhesive properties and ready for use.

The coagulation time of PRP after CaCl instillation was evaluated in 250 μl samples placed in Eppendorf tubes with different CaCl concentrations. Coagulation was determined by the visualization of the clot at 20°C and carried out always by the same person (SG). The first analysis was performed using 5%, 10%, 25% and 50% CaCl concentrations, which were instilled into two PRP samples each from two different animals. A comparison was then made between 5% and 10% CaCl solutions in nine PRP samples, each obtained from five animals. Finally, a test was performed using 5% CaCl solution in 47 PRP samples from twenty one animals (table 1). The samples were observed for two hours and classified as non-coagulated if coagulation had not occurred during this time.

Table 1

The making process of platelet-rich-plasma in rabbits in vitro

1st step

2nd step

3rd step

CaCl concentration

10%

25%

50%

10%

Number of animals

Number of PRP samples

PRP coagulation

yes

Coagulation time (minutes)

- mean

- range

18–25

25–31

10–20

20–50

7–39

- st. Deviation

3.9

10.2

7.4

The platelet count was carried out in the blood drawn and in the PRP sample with a Neubauer camera using the Brecher and Cronkite direct manual method 2425.

In vivo study

PRP preparation was performed in twelve rabbits using the same technique as in the in vitro study, and was activated by 5% CaCl to attach the corneal button as part of the autologous non-perforating corneal transplantation. Topical 5% iodopovidone was preoperatively instilled into the eye and over the eyelids, followed by topical 0.3% ciprofloxacin (Alcon, Sao Pablo, Brazil). Deep anterior keratectomy (one third of the stroma), using a 6-mm-diameter trephine, was done on right eyes under a ZEISS S5-Pro operating microscope (Zeiss C, Overckochen, Germany). The corneal button was excised according to Malbran's peeling off technique 26. The flap was then soaked in autologous PPP and kept at 4°C for about 3 minutes. In the meantime, PRP was activated, transformed into a gel and placed over the stromal surface. The corneal flap was finally replaced on the stroma. Corneal graft adherence was manually verified at the end of the procedure and 30 minutes later using a delicate forceps. A partial tarsorraphy using three 5-0 silk sutures was carried out closing two thirds of the palpebral fissure. Twenty-one percent oxygen was administered to all animals for an hour after awakening. Topical 0.3% ciprofloxacin (Alcon, San Pablo, Brazil) and 0.1% dexamethasone (Poen, Buenos Aires, Argentina) were applied 4 times daily up to 14 and 21 days, respectively. The sutures of the partial tarsorraphy were removed on day 2.

A control group made up of six rabbits underwent lamellar corneal graft. In this group, the corneal button was gently placed on the stroma without using PRP. A tarsorraphy was also performed and removed on day 2.

Follow-up examinations were daily performed during the first week and weekly thereafter, using an operating microscope, a slit-lamp and surgical loupes. Examinations were carried out with special attention to corneal adhesiveness and inflammatory reaction. These features were photographically documented using a Nikon Coolpix 5700 Digital Camera (Nikon, Tokyo, Japan) on day 2, 7, 30 and 90. Histopathological analyses of the specimens were done 2, 7, 30 and 90 days after surgery. Histological specimens were stained with hematoxylin and eosin, periodic acid-Shiff (PAS) and Masson trichrome, and examined with a Nikon Eclipse E800 microscope (Nikon, Tokyo, Japan).

Results

In vitro study

All animals survived the blood extraction. Blood samples were free of clot. PRP was prepared in approximately 40 minutes. The number of platelets in PRP increased with respect to the number of platelets in the blood sample. In the PRP, the mean platelet concentration was 807.564 platelets/mm3 (range 622,000 – 1,350,000, SD 211,490) from an original vein concentration of 320,133 platelets/mm3 (range 280,000 – 408,000, SD 42,323). The resulting Platelet Enrichment Factor 20 was 152%. PRP treated with 25 % and 50% CaCl concentrations never coagulated whereas PRP treated with the 10 % CaCl concentration coagulated at 26 minutes. The mean coagulation time for 47 samples treated with the 5% CaCl concentration was 19 minutes (range 7 – 39, SD 7.4) (table 1).

In vivo study

Animals with PRP showed corneal flap adherence within 20 minutes. An attached graft was seen in all rabbits and corneal clarity was observed from day 30 onwards (Figure 1). Clinical and histopathological examination of the eyes revealed no signs of inflammation. A normal interface between the graft and the host was found at 90 days post-operatively, as well as an intact epithelium (Figure 2). No flap complications such as diffuse lamellar keratitis, wrinkles, displacements or rotation of the flap were observed. A detached corneal flap was seen in all control animals after removing the tarsorraphy.

Figure 1

Clinical and histopathological results 30 days after lamellar corneal transplantation

Clinical and histopathological results 30 days after lamellar corneal transplantation. An attached lamellar flap is seen with a suitable transparency at 30 days postoperative (A). This flap without epithelial defects is seen under Masson technique occupying the superficial third of the cornea.

Figure 2

Clinical and histopathological results 90 days after lamellar corneal transplantation

Clinical and histopathological results 90 days after lamellar corneal transplantation. Clear cornea (A) and attached lamellar flap with a normal appearence (B) (H&E stain, 60×) is seen at 90 days postoperative.

Discussion

We developed a method for making PRP in rabbits, successfully used in non-perforating corneal transplantation. A comparison of methods used for preparing PRP is shown in Table 2. Blood coagulation problems are more frequently seen in female than in male rabbits 20. This observation could influence rabbit PRP production. Anyhow, these differences do not seem to be relevant in humans 27. It should be noted that the blood sample in our investigation had to be collected intracardiacally because we were not able to avoid blood coagulation by using different puncture sites, such as the ear or femoral vein. There is a wide range of variation in the intensity and duration of centrifugation among research studies. Ideal platelet counts differ among researchers. The machine and software used seem to play a role since rabbit derived platelets are smaller than those of humans 8. Rabbits require specific software. That is why we carried out the platelet counts by direct observation. We thought that, by doing so, we would be able to get a more accurate count. Although some researchers have claimed that the best platelet concentration for producing PRP is 1 million/dl, this remains unclear. We tested the adhesiveness of PRP and can conclude that a Platelet Enrichment Factor of 152% seems to be useful at least for soft tissue adhesion.

Table 2

The comparison of methods used for PRP preparation in rabbits

Study

Rabbit

Blood Samples

Centrifugation

Hct

PRP

Platelets cells Count

Activation type

Adhesive Test

Type

1st

2nd

Vein

PRP

Efeoglu et al [20]

Vein

EDTA

300 g/10'

5000 g/5'

555.000

3.134.500

465

not done

Butterfield et al [22]

Ear artery

citrate

150 g/20'

400 g/10'

468.000

2.061.000

340

CaCl + BT

not done

Hokugo et al [28]

citrate

2400 rpm/10'

3600 rpm/10'

0,8

200.000

1.200.000

500

Fib + BT

not done

Ohya et al [29]

203 g/5'

1050 g/5'

227.000

864.000

281

CaCl + BT

not done

Jung et al [30]

citrate

150 g/20'

500 g/20'

0,5

CaCl + BT

not done

Present study

Heart

citrate

72 g/15'

1006 g/5'

320.133

807.564

152

CaCl

done

T: Total; F: Female; M: Male; Hct: Hematocrit; S: Source; AC: Anticoagulation; EDTA: Ethylenediaminetetraacetic acid; NS: Not Specified; CaCl: calcium chloride; Fib: Fibrinogen; BT: Bovine Thrombin; EF: Enrichment Factor

Observation: centrifugation values by Hokugo et al were reported in centrifuge rotor speed (rpm). Not enough data was available to make the conversion to times gravidity (g).

Other tissue adhesives have also been used in lamellar keratoplasty in rabbits and humans 2829 and new synthetic glues like biodendrimer 30 and light-activated 31 adhesives are being tested in ophthalmology. Most of them have functional similarities but differ in origin and compounds. The major difference with PRP is that these commercial products are not autologous 1.

PRP is always autologous. Nevertheless, bovine thrombin has been used to activate PRP in previous studies without respecting the autologous aspect 22323334. In our investigation, a chemical substance (5% CaCl concentration), was found suitable for triggering PRP activation. This could avoid the use of heterologous blood components which can cause immune reactions, and in turn, lead to negative results that could be falsely ascribed to PRP.

Several variables should be carefully monitored during PRP preparation. Special care must be placed on blood extraction tools, machines for blood centrifugation and CaCl solutions to prevent contamination of the compound. The process must be kept sterile and precisely suited to separate platelets from red blood cells. Unless platelet sequestration is done carefully and without causing any damage, platelets will no longer be able to secrete growth factors actively. PRP failure in previous studies may have resulted from non-adherence to these recommendations 21.

PRP, as tissue adhesive, has different applications in medicine 7. It has also been used as carrier for pharmaceutical molecules, as antiangiogenic agents, and growth factors 323536. Gene therapy may benefit from PRP in future investigations since the presence of an adenoviral vector in the gel did not affect its properties 37. It is also worth mentioning the recent use of PRP as cell supporter in corneal limbal epithelial cell transplantation 38.

In this experimental study in rabbits, PRP as an adhesive was able to attach the corneal button in the setting of non-perforating corneal transplantation. The corneal flap, about one third of the corneal thickness, remained attached up to three months post-operatively. Our survey on PRP preparation disclosed several difficulties that are yet to be overcome. This study could be taken as a guideline for rabbit-derived PRP preparation. We hope that the comments and data herein prove useful to researchers of the growing fields of platelet cell and experimental transplantation. Further studies are currently underway to evaluate the corneal wound healing response in the presence of PRP adhesive.

Acknowledgements

This work was supported by a grant from Austral University. We are grateful to Germán Ruffolo and Guillermo Gastón for their skilful technical assistance. We also thank Jorge Mancini and Guillermo Mazzolini for their collaboration.

Platelet-Rich Plasma: Evidence to Support Its Use Marx RE J Oral Maxillofac Surg 2004 62 489 96 10.1016/j.joms.2003.12.003 15085519 Fibroblast proliferation due to exposure to a platelet concentrate in vitro is pH dependent Liu Y Kalen A Risto O Wahlstrom O Wound Repair Regen 2002 10 336 40 10.1046/j.1524-475X.2002.10510.x 12406171 White blood cell fragments in platelet concentrates prepared by the platelet-rich plasma or buffy-coat methods Dijkstra-Tiekstra MJ Van der Schoot CE Pietersz RN Reesink HW Vox Sang 2005 88 275 7 10.1111/j.1423-0410.2005.00634.x 15877650 Fibrin sealant: scientific rationale, production methods, properties, and current clinical use Radosevich M Goubran HI Burnouf T Vox Sang 1997 72 133 43 10.1046/j.1423-0410.1997.7230133.x 9145483 Fibrin seal: The state of the art Matras H J Oral Maxillofac Surg 1985 43 605 11 3891930 Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing Dvorak HF Harvey VS Estrella P Brown LF McDonagh J Dvorak AM Vox Sang 1987 57 673 86 Platelet-rich plasma: clinical applications in dentistry Carlson NE Roach RB Jr J Am Dent Assoc 2002 133 1383 6 12403541 Platelet-rich plasma and bone graft materials: a review and a standardized research protocol Grageda E Implant Dent 2004 13 301 9 15591991 Platelet-rich plasma combined with a porous hydroxyapatite graft for the treatment of intrabony periodontal defects in humans: a comparative controlled clinical study Oku da K Tai H Tanabe K Suzuki H Sato T Kawase T Saito Y Wolff LF Yoshiex H J Periodontol 2005 76 890 8 10.1902/jop.2005.76.6.890 15948682 Efficacy of platelet-rich plasma in alveolar bone grafting Oyama T Nishimoto S Tsugawa T Shimizu F J Oral Maxillofac Surg 2004 62 555 8 10.1016/j.joms.2003.08.023 15122558 Use of autologous platelet-rich plasma (PRP) in periodontal defect treatment after extraction of impacted mandibular third molars Sammartino G Tia M Marenzi G di Lauro AE D'Agostino E Claudio PP J Oral Maxillofac Surg 2005 63 766 70 10.1016/j.joms.2005.02.010 15944972 The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery Man D Plosker H Winland-Brown JE Plast Reconstr Surg 2001 107 229 37 10.1097/00006534-200101000-00037 11176628 Application of single-donor fibrin glue to burns Stuart JD Kenney JG Lettieri J Spotnitz W Baker J J Burn Care Rehabil 1988 9 619 22 2464603 Use of human fibrin glue and amniotic membrane transplant in corneal perforation Duchesne B Tahi H Galand A Cornea 2001 20 230 2 10.1097/00003226-200103000-00027 11248838 Tissue-engineered injectable bone regeneration for osseointegrated dental implants Yamada Y Ueda M Naiki T Nagasaka T Clin Oral Implants Res 2004 15 589 97 10.1111/j.1600-0501.2004.01038.x 15355402 Effect of platelet-rich plasma (PRP) concentration on the viability and proliferation of alveolar bone cells: an in vitro study Choi BH Zhu SJ Kim BY Huh JY Lee SH Jung JH Int J Oral Maxillofac Surg 2005 34 420 4 10.1016/j.ijom.2004.10.018 16053853 Role of platelet-derived growth factor in wound healing Pierce GF Mustoe TA Altrock BW Deuel TF Thomason A J Cell Biochem 1991 45 319 26 10.1002/jcb.240450403 2045423 Potential for osseous regeneration of platelet-rich plasma – a comparative study in mandibular third molar sockets Simon D Maneul S Geetha V Naik BR Indian J Dent Res 2004 15 133 6 16035641 Basic studies on the clinical applications of platelet-rich plasma Yazawa M Ogata H Nakajima T Mori T Watanabe N Handa M Cell Transplant 2003 12 509 18 12953925 A modified method for preparing platelet-rich plasma: an experimental study Efeoglu C Akcay YD Erturk S J Oral Maxillofac Surg 2004 62 1403 7 10.1016/j.joms.2004.06.047 15510363 Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration Weibrich G Hansen T Kleis W Buch R Hitzler WE Bone 2004 34 665 71 10.1016/j.bone.2003.12.010 15050897 Effect of platelet-rich plasma with autogenous bone graft for maxillary sinus augmentation in a rabbit model Butterfield KJ Bennett J Gronowicz G Adams D J Oral Maxillofac Surg 2005 63 370 6 10.1016/j.joms.2004.07.017 15742289 Statement for the Use of Animals in Ophthalmic and Visual Research The Association for Research in Vision and Ophthalmology (ARVO) http://www.arvo.org/eweb/dynamicpage.aspx?site=arvo2&webcode=AnimalsResearch Morphology and enumeration of human blood platelets Brecher G Cronkite EP J Appl Physiol 1950 3 365 77 14794596 The reproducibility and consistency of the platelet count Brecher G Schneiderman M Cronkite EP Am J Clin Pathol 1953 23 15 26 13016502 Lamellar keratoplasty, Malbran's peeling off Technique Polack FM Arch Ophthalmo 1971 86 293 5 Correlation of platelet concentration in platlet-rich plasma to the extraction method, age, sex, and platlet count of the donor Weibrich G Kleis WK Kunz-Kostomanolakis M Loos AH Wagner W Int J Oral Maxillofac Implants 2001 16 693 9 11669252 Use of a platelet-fibrinogen-thrombin mixture as a corneal adhesive: experiments with sutureless lamellar kertaoplasty in the rabbit Rosenthal AR Harbury C Egbert PR Rubenstein E Inv Ophthalmology 1975 14 872 5 Human fibrin tissue adhesive for sutureless lamellar keratoplasty and scleral patch adhesion Kaufman HE Insler MS Ibrahim-Elzembely HA Kaufman SC Ophthalmology 2003 110 2168 72 10.1016/S0161-6420(03)00832-7 14597525 New Dendritic Adhesives for Sutureless Ophthalmic Surgical Procedures Velazquez AJ Carnahan MA Kristinsson J Stinnett S Arch Ophthalmo 2004 122 867 70 10.1001/archopht.122.6.867 A light-activated surgical adhesive technique for sutureless ophthalmic surgery Bloom JN Duffy MT Davis JB McNally-Heintzelman KM Archives of Ophthalmology 2003 121 1591 5 10.1001/archopht.121.11.1591 14609917 Augmented bone regeneration activity of platelet-rich plasma by biodegradable gelatin hydrogel Hokugo A Ozeki M Kawakami O Sugimoto K Mushimoto K Morita S Tabata Y Tissue Eng 2005 11 1224 33 10.1089/ten.2005.11.1224 16144458 Sinus floor elevation applied tissue-engineered bone. Comparative study between mesenchymal stem cells/platelet-rich plasma (PRP) and autogenous bone with PRP complexes in rabbits Ohya M Yamada Y Ozawa R Ito K Takahashi M Ueda M Clin Oral Implants Res 2005 16 622 9 10.1111/j.1600-0501.2005.01136.x 16164471 Platelet-rich plasma and fibrin as delivery systems for recombinant human bone morphogenetic protein-2 Jung RE Schmoekel HG Zwahlen R Kokovic V Hammerle CH Weber FE Clin Oral Implants Res 2005 16 676 82 10.1111/j.1600-0501.2005.01183.x 16307574 Involvement of platelets in stimulating osteogenic activity Slater M Patava J Kingham K J Orthop Res 1995 13 655 63 10.1002/jor.1100130504 7472743 Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation Landesberg R Roy M Gickman RS J Oral Maxillofac Surg 2000 58 297 300 10.1016/S0278-2391(00)90058-2 10716112 Adenoviral vectors do not induce, inhibit, or potentiate human platelet aggregation Eggerman TL Mondoro TH Lozier JN Vostal JG Hum Gene Ther 2002 13 125 8 10.1089/10430340152712674 11779416 The use of autologous platelet gel (platelet-rich-plasma) in corneal limbal epithelial cell transplantation Gallo JE Gimeno FL Roldan F Croxatto JO Genovese J Invest Ophthalmol Vis Sci 2003 44 E-Abstract 1354